SC 13G/A | 2015-02-13 | FMR LLC | Pacira Pharmaceuticals, Inc. | 3,190,622 | 8.8% | EDGAR |
SC 13G/A | 2015-02-11 | VANGUARD GROUP INC | Pacira Pharmaceuticals, Inc. | 2,126,133 | 5.9% | EDGAR |
SC 13G/A | 2015-02-10 | JENNISON ASSOCIATES LLC | Pacira Pharmaceuticals, Inc. | 2,858,248 | 7.9% | EDGAR |
SC 13G/A | 2015-02-10 | GILDER GAGNON HOWE & CO LLC | Pacira Pharmaceuticals, Inc. | 3,026,727 | 8.4% | EDGAR |
SC 13G/A | 2015-01-27 | PRUDENTIAL FINANCIAL INC | Pacira Pharmaceuticals, Inc. | 2,864,310 | 7.9% | EDGAR |
SC 13G/A | 2015-01-26 | BlackRock Inc. | Pacira Pharmaceuticals, Inc. | 2,642,191 | 7.3% | EDGAR |
SC 13D/A | 2014-03-18 | HBM Healthcare Investments (Cayman) Ltd. | Pacira Pharmaceuticals, Inc. | 1,667,307 | 4.9% | EDGAR |
SC 13G/A | 2014-02-14 | FMR LLC | Pacira Pharmaceuticals, Inc. | 3,681,620 | 11.0% | EDGAR |
SC 13G | 2014-02-12 | VANGUARD GROUP INC | Pacira Pharmaceuticals, Inc. | 1,800,818 | 5.4% | EDGAR |
SC 13G | 2014-02-12 | GILDER GAGNON HOWE & CO LLC | Pacira Pharmaceuticals, Inc. | 3,853,499 | 11.5% | EDGAR |
SC 13G/A | 2014-02-11 | PRICE T ROWE ASSOCIATES INC /MD/ | Pacira Pharmaceuticals, Inc. | 4,766,267 | 14.2% | EDGAR |
SC 13G/A | 2014-02-10 | JENNISON ASSOCIATES LLC | Pacira Pharmaceuticals, Inc. | 2,774,988 | 8.3% | EDGAR |
SC 13G | 2014-01-30 | BlackRock Inc. | Pacira Pharmaceuticals, Inc. | 2,182,927 | 6.5% | EDGAR |
SC 13G/A | 2014-01-29 | PRUDENTIAL FINANCIAL INC | Pacira Pharmaceuticals, Inc. | 2,778,253 | 8.3% | EDGAR |
SC 13G | 2013-09-10 | FMR LLC | Pacira Pharmaceuticals, Inc. | 3,550,393 | 10.7% | EDGAR |
SC 13D/A | 2013-07-26 | HBM Healthcare Investments (Cayman) Ltd. | Pacira Pharmaceuticals, Inc. | 1,709,977 | 5.2% | EDGAR |
SC 13D/A | 2013-04-02 | HBM Healthcare Investments (Cayman) Ltd. | Pacira Pharmaceuticals, Inc. | 2,313,026 | 7.1% | EDGAR |
SC 13D/A | 2013-03-21 | Sanderling Venture Partners VI LP | Pacira Pharmaceuticals, Inc. | 416,083 | 1.3% | EDGAR |
SC 13D/A | 2013-03-21 | MPM BioVentures IV QP LP | Pacira Pharmaceuticals, Inc. | 1,283,584 | 3.9% | EDGAR |
SC 13G/A | 2013-02-14 | Visium Asset Management, LP | Pacira Pharmaceuticals, Inc. | 1,600,000 | 4.9% | EDGAR |